Menu
About
Mission
Benefits
Board of Directors
Committees
Join
Corporate Sponsors
Legislative
Newsletters
Presentations
Events
Upcoming Events
Spring Conference
Fall Conference
Webinars
Member Login
06/02/2023
Webinar Treatment Considerations for Certain Patients with Advanced NSCLC
Read More >
03/14/2023
Lilly: New Expanded Indication for Verzenio
Read More >
03/06/2023
Lilly FDA Approved Jaypirca (pirtobrutinib)
Read More >
01/31/2023
Changes to POHMS Membership Dues for 2023!
Read More >
11/17/2022
2023 Corporate Membership
Read More >
09/09/2022
IMPORTANT NOTICE: POHMS Change of Address
Read More >
08/30/2022
Pharmacyclics: Imbruvica cGVHD approval
Read More >
06/07/2022
New Indication: ENHERTU (Daiichi Sankyo Inc)
Read More >
Corporate/Vendors
Upcoming Events
Visit CHOC
Newsletters
Member Resources
